SARAH MASSEY: Open Payments
NPI 1336795871 · SHELBYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 53 payments from 15 companies in 2025. Trend: 2023 $1,072 · 2024 $674 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $214 |
| Lilly USA, LLC | 10 | $188 |
| PFIZER INC. | 7 | $169 |
| ABBVIE INC. | 6 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Novo Nordisk Inc | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: REXULTI, NURTEC ODT, MOUNJARO, VRAYLAR, INGREZZA, JARDIANCE, Kerendia, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
